Last update :
16/06/2024
Analgesic   Butorphanol tartrate  
Injection
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References Pdf
   Chemical structure  

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Dolorex France
Torbugesic France
Stability of mixtures   Injection   Stability of mixtures : Butorphanol tartrate     
Container Solvent Concentration Compound Temperature Storage Duration of stability References
Glass Sodium chloride 0,9% 0.08 mg/ml
Injection   Butorphanol tartrate   
Injection   Droperidol 0.05 mg/ml
25°C
15 Day
Protect from light 3378
Level of evidence A+
Glass Sodium chloride 0,9% 0.08 mg/ml
Injection   Butorphanol tartrate   
Injection   Droperidol 0.05 mg/ml
4°C
15 Day
Protect from light 3378
Level of evidence A+
Polyvinyl chloride Sodium chloride 0,9% 0.08 mg/ml
Injection   Butorphanol tartrate   
Injection   Droperidol 0.05 mg/ml
25°C
15 Day
Protect from light 3378
Level of evidence A+
Polyvinyl chloride Sodium chloride 0,9% 0.08 mg/ml
Injection   Butorphanol tartrate   
Injection   Droperidol 0.05 mg/ml
4°C
15 Day
Protect from light 3378
Level of evidence A+
Polyolefine Sodium chloride 0,9% 0,067 mg/ml
Injection   Butorphanol tartrate   
Injection   Ketamine hydrochloride 1,4 mg/ml
Injection   Droperidol 0,034 mg/ml
25°C
14 Day
Protect from light 4115
Polyolefine Sodium chloride 0,9% 0.05 mg/ml
Injection   Butorphanol tartrate   
Injection   Ropivacain hydrochloride 1 & 2 mg/ml
25°C
15 Day
Protect from light 3780
Level of evidence A
Polyolefine Sodium chloride 0,9% 0,067 mg/ml
Injection   Butorphanol tartrate   
Injection   Ketamine hydrochloride 1,4 mg/ml
Injection   Droperidol 0,034 mg/ml
4°C
14 Day
Protect from light 4115
Polyolefine Sodium chloride 0,9% 0.05 mg/ml
Injection   Butorphanol tartrate   
Injection   Ropivacain hydrochloride 1 & 2 mg/ml
4°C
15 Day
Protect from light 3780
Level of evidence A

  Mentions Légales